Celldex Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $31k | 735 | 41.97 |
| 2023-09-30 | $52k | 1.9k | 27.52 |
| 2023-06-30 | $148k | 4.4k | 33.93 |
| 2023-03-31 | $78k | 2.2k | 35.81 |
| 2022-12-31 | $0 | 309 | 0.00 |
| 2022-09-30 | $192k | 6.8k | 28.28 |
| 2022-06-30 | $307k | 11k | 26.96 |
| 2022-03-31 | $111k | 3.3k | 34.05 |
| 2021-12-31 | $139k | 3.6k | 38.78 |
| 2021-09-30 | $654k | 12k | 54.03 |
| 2021-06-30 | $45k | 1.3k | 33.41 |
| 2020-12-31 | $124k | 7.1k | 17.58 |
| 2020-03-31 | $0 | 4.8k | 0.00 |
| 2019-12-31 | $11k | 4.8k | 2.30 |
| 2019-09-30 | $5.0k | 2.5k | 2.01 |
| 2019-03-31 | $9.0k | 1.7k | 5.21 |
More positions owned by Tower Research Capital
Home Depot (HD)
View all positions for Tower Research Capital